Sort publications on year

  • Biometry and database analysis

    Effectiveness of sequencing TKIs in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC): A French national medical-administrative claim database analysis

    GIRARD N, BOUEE S, MORO-SIBILOT D, EMERY C, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C

    Annals of Oncology ; 2019;30(5):v627-v628

  • Biometry and database analysis

    Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France

    POURCHER V, GOURMELEN J, BUREAU I, BOUEE S

    PLOS ONE ; 2020;15(12),e0243529

  • Biometry and database analysis

    Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database

    EMERY C, TORRETON E, DEJAGER S, LEVY-BACHELOT L, BINEAU S, DETOURNAY B.

    Diabetes Ther ; 2020;11(2):535-548

  • Biometry and database analysis

    Profile of Women Initiated on Denosumab and Pattern of Use in a Restricted Postmenopausal Osteoporosis Indication: A French Database Analysis Over the Period 2013-2014.

    EMERY C, GOURMELEN J, FAGNANI F, SUZAN F, DESAMERICQ G, FARDELLONE P.

    Adv Ther ; 2019;36(4),969-975

  • Biometry and database analysis

    Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.

    EMERY C, TORRETON E, BRIERE JB, THOMAS EVERS T, FAGNANI F.

    J Med Econ ; 2020;23(5):513-520

  • Biometry and database analysis

    The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database

    BOURDIN A, FABRY-VENDRAND C, OSTINELLI J, AIT-YAHIA M, DARNAL E, BOUEE S, LAURENDEAU C, BUREAU I, GOURMELEN J, CHOUAID C.

    J Allergy Clin Immunol Pract ; 2019;7(5):1477-1487

  • Biometry and database analysis

    Migraine burden and costs in france: a nationwide claims database analysis of triptan users.

    DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.

    J Med Econ ; 2019

  • Biometry and database analysis

    Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.

    LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.

    J Med Econ ; 2019

  • Biometry and database analysis

    Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice : Mimosa study

    ROTTEMBOURG J, URENA-TORRES P, TOLEDANO D, GUEUTIN V, HAMANI A, COLDEFY O, HEBIBI H, GUINCESTRE T, EMERY C.

    Clinical Kidney Journal ; 2019;12(6):871-879

  • Biometry and database analysis

    An attempt at modeling COPD epidemiological trends in France

    BURGEL PR, LAURENDEAU C, RAHERISON C, FUHRMAN C, ROCHE N.

    Respir Res ; 2018;19(1):130

  • Biometry and database analysis

    Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)

    PHILIPPE F, BLIN P, BOUÉE S, LAURENDEAU C, TORRETON E, GOURMELIN J, VELKOVSKI-ROUYER M, LEVY-BACHELOT L, STEG G.

    Ann Cardiol Angeiol ; 2017;66(2):74-80

  • Biometry and database analysis

    Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.

    AGOSTINI A, GODARD C, LAURENDEAU C, BENMAHMOUD ZOUBIR A, LAFUMA A, LÉVY-BACHELOT L, GOURMELEN J, LINET T.

    Eur J Contracept Reprod Health Care ; 2018;23(6):421-426

  • Biometry and database analysis

    Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database

    DALLONGEVILLE J, SACHER F, BOUEE S , EMERY C, BUREAU I, GOURMELEN J, FAUCHIER L.

    Therapie ; 2018;73:449-460

  • Biometry and database analysis

    Heparin-Induced Thrombocytopenia : An estimate of the average cost in the hospital setting in France

    ELALAMY I, LE GAL G, NACHIT-OUINEKH F, LAFUMA A, EMERY C, LE FUR C, CHAPUIS F

    Clin Appl Thromb Hemost ; 15(4):428-34

  • Biometry and database analysis

    Costs of cardiovascular events of diabetic patients in French hospitals

    COLIN X, LAFUMA A, GUERON B

    Diabetes Metab ; 2017;33(4):310-313